Deepcell Revenue and Competitors
Estimated Revenue & Valuation
- Deepcell's estimated annual revenue is currently $27.9M per year.
- Deepcell's estimated revenue per employee is $193,750
- Deepcell's total funding is $25M.
Employee Data
- Deepcell has 144 Employees.
- Deepcell grew their employee count by 0% last year.
Deepcell's People
Name | Title | Email/Phone |
---|---|---|
1 | AI Tech Lead | Reveal Email/Phone |
Deepcell Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Deepcell?
A novel way to identify and sort cells. Our mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease.
keywords:N/A$25M
Total Funding
144
Number of Employees
$27.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Deepcell News
--(BUSINESS WIRE)--Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational...
AI-driven Deepcell raises $73M to further single-cell imaging tech ... With artificial intelligence being treated as the next frontier of drug...
Deepcell is helping to advance precision medicine by combining advances in AI, cell classification and capture, and single-cell analysis to...
Deepcell, a Silicon Valley startup spun out of Stanford University in 2017 with a novel way to identify cells using AI, today raised $20 million. The company says the funds will be put toward bolstering development of its technology and enabling it to drive a “hypothesis-free” approach to cell c ...
Deepcell, a Mountain View, Calif.-based life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, closed its Series A round of financing with $20m. The round was led by Bow Capital and joined by Andreessen Horowitz, which led its $ ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20.1M | 144 | -6% | $171.5M |
#2 | $53M | 146 | 23% | N/A |
#3 | $22M | 146 | -20% | $115.4M |
#4 | $32.5M | 148 | -11% | $69M |
#5 | $23.8M | 149 | -7% | N/A |